1. Rethinking Resection and Transplant Candidacy for HCC: Should Tumor Biology Replace Size-Based Criteria?

   • Alexandra W. Acher
   • Daniel E. Abbott

   Hepatobiliary Tumors 14 November 2019 Pages: 1309 - 1311

2. Deciphering the Molecular Landscape of Appendiceal Mucinous Neoplasms for Diagnostic, Prognostic and Therapeutic Purposes

   • Haroon A. Choudry
   • David L. Bartlett

   Peritoneal Surface Malignancy 23 January 2020 Pages: 1312 - 1313

3. Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma

   • Audrey E. Kam
   • Sam G. Pappas
   • Ashiq Masood

   Gastrointestinal Oncology 17 December 2019 Pages: 1314 - 1315

4. Esophageal Cancer and Surgical Margins: When a Positive Is a Negative

   • Stephanie G. Worrell

   Thoracic Oncology 03 January 2020 Pages: 1316 - 1317

5. Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM

   • M. Susan Hallbeck
   • Katherine E. Law
   • Judy C. Boughey

   Health Services Research and Global Oncology Open access 08 January 2020 Pages: 1318 - 1326

   

6. ASO Author Reflections: Poor Ergonomics During Surgical Procedures May Lead to Work-Related Pain and Early Retirement

   • M. Susan Hallbeck
   • Katherine E. Law
   • Judy C. Boughey

   ASO Author Reflections 28 February 2020 Pages: 1327 - 1328

7. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma

   • Dhaval Patel
   • John E. Phay
   • Lawrence T. Kim

   Endocrine Tumors 28 February 2020 Pages: 1329 - 1337

   

8. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma

   • Dhaval Patel
   • John E. Phay
   • Carmen C. Solórzano

   Endocrine Tumors 28 February 2020 Pages: 1338 - 1347

   

9. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?

   • Elettra Merola
   • Anja Rinke
   • Marianne E. Pavel

   Endocrine Tumors 12 November 2019 Pages: 1348 - 1355

   

10. Lessons Learned from the Transoral Endoscopic Thyroidectomy with Vestibular Approach (TOETVA) for the Treatment of Thyroid Carcinoma

    • Kuauhyama Luna-Ortiz
    • Antonio Gómez-Pedraza
    • Angkoon Anuwong

    Endocrine Tumors 20 November 2019 Pages: 1356 - 1360

11. Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients

    • Yongcong Yan
    • Qianlei Zhou
    • Zhiyu Xiao

    Hepatobiliary Tumors 26 November 2019 Pages: 1361 - 1371

    

12. ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study

    • Jun Li
    • Mohamed Moustafa
    • Silvio Nadalin

    Hepatobiliary Tumors Open access 30 January 2020 Pages: 1372 - 1384

    

13. ASO Author Reflections: Optimizing the Oncological Outcome for Locally Advanced Intrahepatic Cholangiocarcinoma

    • Jun Li
    • M. Moustafa
    • A. Heumann

    ASO Author Reflections Open access 02 March 2020 Pages: 1385 - 1386

14. How Many Steps Per Day are Necessary to Prevent Postoperative Complications Following Hepato-Pancreato-Biliary Surgeries for Malignancy?

    • Hiroki Nakajima
    • Yukihiro Yokoyama
    • Masato Nagino

    Hepatobiliary Tumors 23 January 2020 Pages: 1387 - 1397

    

15. ASO Author Reflections: Please Walk at Least 5000 Steps per Day before Major Hepato-Pancreato-Biliary (HPB) Surgeries for Malignancy

    • Yukihiro Yokoyama
    • Hiroki Nakajima
    • Masato Nagino

    ASO Author Reflections 02 March 2020 Pages: 1398 - 1399

16. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes

    • Jon M. Harrison
    • Jennifer Y. Wo
    • Carlos Fernandez-del Castillo

    Hepatobiliary Tumors 22 November 2019 Pages: 1400 - 1406

    

17. The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB–IIC Patients—Results After 3 Years

    • Eric A. Deckers
    • Josette E. H. M. Hoekstra-Weebers
    • Harald J. Hoekstra

    Melanoma Open access 18 September 2019 Pages: 1407 - 1417

    

18. ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified

    • Anne Brecht Francken
    • Josette E. H. M. Hoekstra-Weebers
    • Harald J. Hoekstra

    ASO Author Reflections Open access 03 September 2019 Pages: 1418 - 1419

19. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients

    • Jüri Teras
    • Hidde M. Kroon
    • John F. Thompson

    Melanoma 09 March 2020 Pages: 1420 - 1429

    

20. ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective

    • Jüri Teras
    • Hidde M. Kroon
    • Jonathan S. Zager

    ASO Author Reflections 06 March 2020 Pages: 1430 - 1431

21. Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma

    • Jennifer J. Kwak
    • Adam L. Kesner
    • Nicole Kounalakis

    Melanoma 26 November 2019 Pages: 1432 - 1438

    

22. Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Jing Su
    • Guangxu Jin
    • Edward A. Levine

    Peritoneal Surface Malignancy 24 January 2020 Pages: 1439 - 1447

    

23. The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis

    • Eliahu Bekhor
    • Jacquelyn Carr
    • Deepa Magge

    Peritoneal Surface Malignancy 23 December 2019 Pages: 1448 - 1455

24. ASO Author Reflections: Major Late Complication Rates are Higher for Patients Who Underwent Iterative CRS\HIPEC When Compared to a Singular Procedure

    • Eliahu Bekhor
    • Deepa Magge

    ASO Author Reflections 02 March 2020 Pages: 1456 - 1457

25. Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction

    • Aditi Bhatt
    • Olivier Glehen

    Peritoneal Surface Malignancy 21 January 2020 Pages: 1458 - 1470

    

26. ASO Author Reflections: Tailoring the Extent of Peritoneal Resection for Peritoneal Metastases According to the Primary Tumor Site

    • Aditi Bhatt
    • Olivier Glehen

    ASO Author Reflections 11 March 2020 Pages: 1471 - 1472

27. Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma

    • Eric M. Groh
    • Shreya Gupta
    • Jeremy L. Davis

    Gastrointestinal Oncology 20 November 2019 Pages: 1473 - 1479

    

28. Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study

    • Zeping Huang
    • Yutong Chen
    • Youcheng Zhang

    Gastrointestinal Oncology 27 November 2019 Pages: 1480 - 1487

    

29. Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma

    • Qifeng Wang
    • Lin Peng
    • Jinyi Lang

    Thoracic Oncology 23 January 2020 Pages: 1488 - 1495

    

30. Margin Positivity in Resectable Esophageal Cancer: Are there Modifiable Risk Factors?

    • Cary Jo R. Schlick
    • Rhami Khorfan
    • David J. Bentrem

    Thoracic Oncology 13 January 2020 Pages: 1496 - 1507

    

31. ASO Author Reflections: Margin Positivity Following Esophageal Cancer Resection is Associated with Treatment Decisions

    • Cary Jo R. Schlick
    • David J. Bentrem

    ASO Author Reflections 20 February 2020 Pages: 1508 - 1509

32. Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma

    • Takeshi Suzuki
    • Akihiko Okamura
    • Keisho Chin

    Thoracic Oncology 09 December 2019 Pages: 1510 - 1517

    

33. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?

    • Takeshi Suzuki
    • Akihiko Okamura
    • Keisho Chin

    ASO Author Reflections 27 February 2020 Pages: 1518 - 1519

34. Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study

    • Jorianne Boers
    • Annalie Joldersma
    • Jan Willem B. de Groot

    Thoracic Oncology 11 December 2019 Pages: 1520 - 1528

    

35. ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer

    • Jorianne Boers
    • Jan Willem B. de Groot

    ASO Author Reflections 28 February 2020 Pages: 1529 - 1529

36. Esophagectomy for Esophageal Cancer in a Patient with Left Pulmonary Artery Sling

    • Keita Takahashi
    • Akihiko Okamura
    • Masayuki Watanabe

    Thoracic Oncology 12 December 2019 Pages: 1530 - 1530

37. ASO Author Reflections: Cervicothoracoscopic Esophagectomy for Esophageal Cancer

    • Keita Takahashi
    • Akihiko Okamura
    • Masayuki Watanabe

    ASO Author Reflections 02 March 2020 Pages: 1531 - 1532

38. Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon

    • Beth A. Helmink
    • Christina L. Roland
    • Jennifer A. Wargo

    Translational Research and Biomarkers 21 January 2020 Pages: 1533 - 1545

    

39. Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma

    • Xiang-Nan Yu
    • Guang-Cong Zhang
    • Ji-Min Zhu

    Translational Research and Biomarkers 10 March 2020 Pages: 1546 - 1557

    

40. ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma

    • Xiang-Nan Yu
    • Xi-Zhong Shen
    • Ji-Min Zhu

    ASO Author Reflections 12 March 2020 Pages: 1558 - 1559

41. Prolonged Length of Stay After Robotic Prostatectomy: Causes and Risk Factors

    • Marshall C. Strother
    • Katharine F. Michel
    • David I. Lee

    Urologic Oncology 26 February 2020 Pages: 1560 - 1567

    

42. ASO Author Reflections: Prolonged Length of Stay After Robotic-Assisted Radical Prostatectomy—A Separate Problem from Perioperative Complications

    • Katharine F. Michel
    • Marshall C. Strother
    • David I. Lee

    ASO Author Reflections 06 March 2020 Pages: 1568 - 1569

43. Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum

    • Ian P. Hayes
    • Elasma Milanzi
    • Jeanette C. Reece

    Colorectal Cancer 26 November 2019 Pages: 1570 - 1579

    

44. The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival

    • Nelleke P. M. Brouwer
    • Dave E. W. van der Kruijssen
    • Johannes H. W. de Wilt

    Colorectal Cancer Open access 02 December 2019 Pages: 1580 - 1588

    

45. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer

    • Glauco Baiocchi
    • Henrique Mantoan
    • Louise De Brot

    Gynecologic Oncology 04 November 2019 Pages: 1589 - 1594

46. Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia

    • Bofeng Chen
    • Maxwell T. Trudeau
    • Charles M. Vollmer Jr.

    Pancreatic Tumors 05 November 2019 Pages: 1595 - 1605

    

47. Main Pancreatic Duct to Parenchymal Thickness Ratio at Preoperative Imaging is Associated with Overall Survival in Upfront Resected Pancreatic Cancer

    • Marta Sandini
    • Adrian A. Negreros-Osuna
    • Carlos Fernández-del Castillo

    Pancreatic Tumors 13 November 2019 Pages: 1606 - 1612

    

48. The ‘TRIANGLE Operation’ by Laparoscopy: Radical Pancreaticoduodenectomy with Major Vascular Resection for Borderline Resectable Pancreatic Head Cancer

    • Edoardo Rosso
    • Giuseppe Zimmitti
    • Marco Garatti

    Pancreatic Tumors 04 December 2019 Pages: 1613 - 1614

49. ASO Author Reflections: Mini-invasive Pancreaticoduodenectomy—Moving from Feasible to Radical

    • Edoardo Rosso
    • Antonio Iannelli

    ASO Author Reflections 09 March 2020 Pages: 1615 - 1616

50. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients

    • Andrea V. Barrio
    • Stephanie Downs-Canner
    • Monica Morrow

    Breast Oncology 09 December 2019 Pages: 1617 - 1624